The paper entitled "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211" discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis [...].

Reply to Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211 / A. Casiraghi, C.G.M. Gennari, U.M. Musazzi, M.A. Ortenzi, S. Bordignon, P. Minghetti. - In: PHARMACEUTICS. - ISSN 1999-4923. - 12:9(2020 Aug 28).

Reply to Comment on Casiraghi et al. ‘Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis’ 2020, 12, 211

A. Casiraghi
Primo
Writing – Original Draft Preparation
;
C.G.M. Gennari
Secondo
;
U.M. Musazzi;M.A. Ortenzi;S. Bordignon;P. Minghetti
Ultimo
Writing – Review & Editing
2020

Abstract

The paper entitled "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis Pharmaceutics 2020, 12, 211" discusses the physicochemical and technological characterization of a formulation to treat eosinophilic esophagitis [...].
Settore CHIM/09 - Farmaceutico Tecnologico Applicativo
28-ago-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
pharmaceutics-Reply Zur.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 342.64 kB
Formato Adobe PDF
342.64 kB Adobe PDF Visualizza/Apri
pharmaceutics-12-00822.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 170.56 kB
Formato Adobe PDF
170.56 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/763279
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact